News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
1–36
Matches
1940
Sources here
20
Companies here
18
Search results Stored financial headlines

Active search

1940 matching headlines

Ticker or company: ELIMain company stories
Clear
Latest

finance.yahoo.com Earnings

Why Eli Lilly (LLY) Stock Is Up Today

Why Eli Lilly (LLY) Stock Is Up Today What Happened? Shares of global pharmaceutical company Eli Lilly (NYSE:LLY) jumped 3% in the afternoon session after the company announced two deals, acquiring rights to a preclinical Alzheimer's drug and entering a collaboration for an ion channel program. According to a company press release, Eli Lilly acquired global rights to …

Eli Lilly (LLY) Adds Neuroscience And Lung Cancer Research Deals

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Eli Lilly (NYSE: LLY) announced new global collaborations focused on ion channel drug discovery with OmniAb and a trial partnership with Amplia Therapeutics …

LLY main company LLY main company LILY34 main company LLY main company LLYC main company LLY main company +1 more
Sharemaestro market context Trend signal active 52 weeks +52.4% LLY stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Eli Lilly and Company (NYSE:LLY) Stock Price Up 3.7% - What's Next?

Eli Lilly and Company (NYSE:LLY) shares increased by 3.7% to approximately $1,227, driven by optimism regarding its oral obesity drug prospects and positive developments for its next-generation candidate, retatrutide. The company is also expanding its pipeline through collaborations, including an ion-channel program with OmniAb …

LLY main company
Sharemaestro market context Trend signal active 52 weeks +66.6% · Next-week setup positive 58.3% LLY stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

Eli Lilly and Co(LLY.US) Officer Sells US$7.64 Million in Common Stock

An officer at Eli Lilly and Co (LLY.US) sold 9,936 shares of common stock for a total of $7.64 million on August 16, 2026, at an average price of $769.19 per share. This transaction was disclosed in a Form 4 filing with the SEC. …

LLY main company
Sharemaestro market context Trend signal active 52 weeks +66.6% · Next-week setup positive 58.3% LLY stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Eli Lilly and Co Stock (LLY) Moved Up by 3.19% on Aug 18: What Signal Does It Send?

Eli Lilly and Co (LLY) stock rose 3.19% on August 18, driven by strong second-quarter earnings, an upgraded full-year outlook, and high demand for its Mounjaro and Zepbound treatments. Analysts have issued "Buy" ratings with an average price target of $1296.81, reflecting investor confidence …

LLY main company
Sharemaestro market context Trend signal active 52 weeks +66.6% · Next-week setup positive 58.3% LLY stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Eli Lilly Stock Jumps 2.6% as Investors Flee Expensive Tech

This article first appeared on GuruFocus. Eli Lilly (NYSE:LLY), the pharmaceutical powerhouse behind Mounjaro and Zepbound, jumped approximately 2.6% to $1,213.76 Tuesday morning as investors searched for earnings growth outside pressured technology stocks. With its market capitalization climbing above $1.08 trillion, Lilly is proving …

LLY main company LLY main company LILY34 main company LLY main company LLYC main company LLY main company +1 more
Sharemaestro market context Trend signal active 52 weeks +52.4% LLY stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Eli Lilly, Stock Of The Day, Is Erasing Novo's Early Lead In Weight-Loss Pills

Eli Lilly is Tuesday's IBD Stock Of The Day. Shares are staring down two potential entries as the weight-loss kingpin gains on Novo Nordisk. Continue Reading

LLY main company LLY main company LILY34 main company LLY main company LLYC main company LLY main company +1 more
Sharemaestro market context Trend signal active 52 weeks +52.4% LLY stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Eli Lilly's Zepbound Sales Jump 46%, Dominating Obesity Market

Eli Lilly's Zepbound has seen a significant 46% increase in sales, positioning it as a dominant player in the obesity market. This growth highlights the drug's strong performance and its increasing impact within the pharmaceutical industry.

LLY main company
Sharemaestro market context Trend signal active 52 weeks +66.6% · Next-week setup positive 58.3% LLY stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Elicio Therapeutics' (ELTX) "Buy" Rating Reaffirmed at HC Wainwright

HC Wainwright has reaffirmed its "Buy" rating for Elicio Therapeutics (ELTX), with an average analyst price target of $19.75, indicating a "Moderate Buy" consensus. Despite this, ELTX shares opened down 2.3% at $3.02, trading below key moving averages and near its 52-week low. The …

ELTX main company
Sharemaestro market context Price below Trend Line 52 weeks -73.8% ELTX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Why Is Omniab Stock Rallying After Eli Lilly Deal?

OmniAb, Inc. (NASDAQ: OABI) shares surged after the company announced a global collaboration and license agreement with Eli Lilly and Company (NYSE: LLY) for an ion channel program. The deal includes an upfront payment and up to $370 million in potential milestone payments, along …

LLY main company
Sharemaestro market context Trend signal active 52 weeks +66.6% · Next-week setup positive 58.3% LLY stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Elicio Therapeutics stock price target reiterated at $23 by H.C. Wainwright

H.C. Wainwright has reiterated a Buy rating and a $23 price target for Elicio Therapeutics (NASDAQ:ELTX) after the company reported its second-quarter 2026 results. Despite a significant stock price drop, analyst consensus remains at Strong Buy, and the company has secured $15 million in …

ELTX main company
Sharemaestro market context Price below Trend Line 52 weeks -73.8% ELTX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Pallas Capital Advisors LLC Invests $1.67 Million in Exelixis, Inc. $EXEL

Pallas Capital Advisors LLC has invested $1.67 million in Exelixis, Inc. by purchasing 30,721 shares in the second quarter. Institutional investors and hedge funds collectively own a significant 85.27% of the biotechnology company's stock. Exelixis recently reported strong quarterly earnings, beating EPS estimates, and …

EXEL main company
Sharemaestro market context Trend signal active 52 weeks +32.6% · Next-week setup positive 55.4% EXEL stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Barclays Reaffirms Their Buy Rating on Eli Lilly & Co (LLY)

Barclays analyst Emily Field has reiterated a Buy rating on Eli Lilly & Co (LLY) with a price target of $1,400.00. This comes after Eli Lilly reported strong quarterly revenues of $22.97 billion and a net profit of $7.1 billion, significantly up from the …

LLY main company
Sharemaestro market context Trend signal active 52 weeks +66.6% · Next-week setup positive 58.3% LLY stored weekly price path from 22 Aug 2025 to 14 Aug 2026

135,551 Shares in Pembina Pipeline Corp. $PBA Acquired by K.J. Harrison & Partners Inc

K.J. Harrison & Partners Inc. acquired 135,551 shares of Pembina Pipeline Corp. (NYSE:PBA) valued at approximately $6.26 million during the second quarter, making it their 28th biggest holding. Other institutional investors also adjusted their positions in the company, with total institutional ownership standing at …

PBA main company
Sharemaestro market context Trend signal active 52 weeks +36.0% · Next-week setup positive 57.6% PBA stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Diamond Hill Capital Management LLC Investment Advisor Purchases Shares of 14,061 Helios Technologies, Inc $HLIO

Diamond Hill Capital Management LLC has acquired 14,061 shares of Helios Technologies, Inc (HLIO), valued at approximately $1.26 million, marking a new position for the investment advisor. Helios Technologies recently reported strong quarterly earnings, beating estimates with $0.88 EPS and a 9.1% revenue increase …

HLIO main company
Sharemaestro market context Trend signal active 52 weeks +51.0% HLIO stored weekly price path from 22 Aug 2025 to 14 Aug 2026

27,109 Shares in Exelixis, Inc. $EXEL Purchased by Grandfield & Dodd LLC

Grandfield & Dodd LLC has acquired 27,109 shares of Exelixis, Inc. (NASDAQ:EXEL) during the second quarter, valued at approximately $1.48 million. This purchase contributes to the 85.27% of the stock already owned by institutional investors. Despite the company beating earnings estimates with $0.91 per …

EXEL main company
Sharemaestro market context Trend signal active 52 weeks +32.6% · Next-week setup positive 55.4% EXEL stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Helix Acquisition Corp. III Gets Nasdaq Deficiency Notice for Falling Below 300 Total Holders

Helix Acquisition Corp. III (NASDAQ: HLXC) received a Nasdaq deficiency notice because it failed to maintain the required minimum of 300 Total Holders for continued listing on the Nasdaq Global Market. The company has 45 days to submit a compliance plan, and failure to …

HLXC main company
Sharemaestro market context Trend signal started 30 weeks +7.3% · Next-week setup negative 33.3% HLXC stored weekly price path from 23 Jan 2026 to 14 Aug 2026

Form 8K HELIX ACQUISITION CORP. III For: 17 August By Investing.com

The article reports on HELIX ACQUISITION CORP. III's Form 8K filing for August 17th. It is a brief announcement from Investing.com, providing basic information about the filing and the company. The article also includes various market data and other news but focuses on this …

HLXC main company
Sharemaestro market context Trend signal started 30 weeks +7.3% · Next-week setup negative 33.3% HLXC stored weekly price path from 23 Jan 2026 to 14 Aug 2026

Is Fidelity National Information Services Inc (FIS) a Bargain After 4.1% Drop? GF Value Says Undervalued

Fidelity National Information Services Inc (FIS) shares dropped 4.1% to $41.17 on August 17, 2026, making it appear significantly undervalued according to GuruFocus's GF Value™ of $91.62. Despite a high GF Score™ of 62/100, indicating strengths in growth and profitability, the valuation carries a …

FIS main company
Sharemaestro market context Price below Trend Line 52 weeks -38.2% FIS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Helix Acquisition Corp. III receives Nasdaq notice for holder deficiency

Helix Acquisition Corp. III (HLXC) announced it received a notice from Nasdaq for not complying with the listing rule requiring at least 300 total holders. The company has 45 days to submit a plan to regain compliance, with a potential extension of up to …

HLXC main company
Sharemaestro market context Trend signal started 30 weeks +7.3% · Next-week setup negative 33.3% HLXC stored weekly price path from 23 Jan 2026 to 14 Aug 2026

Plains All American (NYSE: PAA) grants CEO 373K phantom units

Plains All American Pipeline LP's Chairman & CEO, Willie CW Chiang, exercised 346,357 Phantom Units into Common Units on August 14, 2026, with 136,292 Common Units withheld for tax liabilities. Concurrently, on August 13, 2026, he received a new grant of 373,000 Phantom Units …

PAA main company
Sharemaestro market context Trend signal active 52 weeks +44.4% · Next-week setup positive 58.5% PAA stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Plains All American (NYSE: PAA) exec gifts 388,579 units to family partnership after exercise

Plains All American (NYSE: PAA) executive Jeremy L. Goebel reported multiple equity-compensation transactions, including exercising 640,691 Phantom Units, withholding 252,112 Common Units for taxes, and gifting 388,579 Common Units to a family limited partnership on August 14, 2026. This resulted in the family partnership …

PAA main company
Sharemaestro market context Trend signal active 52 weeks +44.4% · Next-week setup positive 58.5% PAA stored weekly price path from 22 Aug 2025 to 14 Aug 2026

ELI LILLY & Co SEC Filing (Aug 17, 2026)

Eli Lilly & Co. has filed a Form 144 with the SEC on August 17, 2026, indicating a proposed sale of 6,500 shares of common stock with an aggregate market value of $7,638,150. The securities were acquired on February 10, 2025, as a stock …

LLY main company
Sharemaestro market context Trend signal active 52 weeks +66.6% · Next-week setup positive 58.3% LLY stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Plains All American (NYSE: PAA) grants 59,200 units via incentive plan

Plains All American Pipeline LP (NYSE: PAA) has granted 59,200 Common Units through an indirect acquisition by Plains AAP, L.P. This transaction occurred under an Omnibus Agreement, linking the issuance of PAA units to

PAA main company
Sharemaestro market context Trend signal active 52 weeks +44.4% · Next-week setup positive 58.5% PAA stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context